Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PZBQW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2024110905A1 ADC2-10
|
|||||
| Synonyms |
WO2024110905A1 ADC2-10
Click to Show/Hide
|
|||||
| Organization |
BEIGENE, LTD. | BEIGENE SWITZERLAND GMBH
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Structure |
|
|||||
| Antibody Name |
undisclosed
|
|||||
| Antigen Name |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Linker of ADC2-10
|
Linker Info | ||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||